University of California, San Francisco Logo

University of California, San Francisco | About UCSF | Search UCSF | UCSF Medical Center

Home > CME > HIV Prevention > Slides
Treatment Guidelines and the Interface with Prevention
Slide 1.
Treatment Guidelines and the Interface with Prevention
Slide 1.
Comprehensive Guideline Summary
Slide 2.
Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents
Slide 3.
What the Guidelines Address
Slide 4.
Websites to Access the Guidelines
Slide 5.
Goals of Treatment
Slide 6.
Tools to Achieve Treatment Goals
Slide 7.
Improving Adherence
Slide 8.
Use of HIV RNA Levels to Guide Therapy Decisions
Slide 9.
When to Start ART
Slide 10.
When to Start ART
Slide 11.
Potential Benefits of Early Therapy
Slide 12.
Potential Benefits of Early Therapy
Slide 13.
Potential Benefits of Early Therapy
Slide 14.
Potential Limitations of Early Therapy
Slide 15.
Recommendations for Initiating ART
Slide 16.
Recommendations for Initiating ART
Slide 17.
Recommendations for Initiating ART
Slide 18.
Consider More Rapid Initiation of ART
Slide 19.
Consider Deferral of ART
Slide 20.
About This Slide Set
Slide 21.
Four Prevention Opportunities
Slide 22.
ART to Prevent Sexual Transmission of HIV
Slide 	23.
HIV Infection Rates in the Tenofovir and Placebo Gel Groups: Kaplan-Meier Survival Probability
Slide 24.
Current and Proposed Systemic PrEP Trials
Slide 25.
Four Prevention Opportunities
Slide 26.
HPTN 052 Prevention Results
Slide 27.
HPTN 052 Clinical Results
Slide 28.
HPTN 052 Conclusions
Slide 29.
Unanswered Questions
Slide 30.
When to Start Therapy: Balance Has Tipped Further in Favor of Earlier Initiation
Slide 31.
Relative Time on Treatment...
Slide 32.
Relative Time on Treatment...
Slide 33.
Ms. B.
Slide 34.
Case of Ms. B.
Slide 35.